Improvement in staging of esophageal cancer with the addition of positron emission tomography

Annals of Thoracic Surgery

Volumn 64, Issue 3, 1997, Pages 770-777

  Block, Mark I ^a   Patterson, G Alexander ^a,b   Sundaresan, R Sudhir ^a   Bailey, Marci S ^a   Flanagan, Fidelma L ^a   Dehdashti, Farrokh ^a   Siegel, Barry A ^a   Cooper, Joel D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; CONTRAST MEDIA; DEOXYGLUCOSE; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030819426     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00619-X     Document Type: Article

References (16)

1. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
2. Poplin EA, Khanuja PS, Kraut MJ, et al. Chemoradiotherapy of esophageal carcinoma. Cancer 1994;74:1217-24.
3. Wadler S, Haynes H, Beitler JJ, et al. Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Cancer 1996;78:30-4.
4. Peters JH, Hoeft SF, Heimbucher J, et al. Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg 1994;129:534-9.
5. Chandawarkar RY, Kakegawa R, Fujita H, Yamana H, Hayabuthi N. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol 1996;61:214-7.
6. Sugarbaker DJ, Jaklitsch MT, Liptay MJ. Thoracoscopic staging and surgical therapy for esophageal cancer. Chest 1995; 107:218S-23S.
7. Rigo P, Paulus P, Kaschten BJ, et al. Oncological application of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74.
8. 18F]-FDG in oncology: a clinical update. Nucl Med Biol 1996;23:717-35.
9. Warburg O. On the origin of cancer cells. Science 1956;123: 309-14.
10. 18F-2-deoxy2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron emission tomography. Cancer 1991;67:1544-50.
11. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer. A prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-8.
12. Yasuda S, Raja S, Hubner K. Application of whole-body positron emission tomography in the imaging of esophageal cancer: report of a case. Surg Today 1995;25:261-4.
13. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with FDG-PET. AJR 1997;168:417-24.
14. 18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol 1990;17:273-9.
15. Xu M, Luk WK, Cutler PD, Digby WM. Local threshold for segmented attenuation correction of PET imaging of the thorax. IEEE Trans Nucl Sci 1994;41:1532-7.
16. Strauss GL. F-18-deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nuc Med 1996;23:1409-15.